top of page

Age Related Macular Degeneration

Introduction

Progressive chronic degeneration of the PR, RPE, BM and choriocapillaris primarily affecting central vision. This is progression risk rises with age.
- Vision loss is usually due to neovascularisation or geographic atrophy
- Worldwide, prevalence for 45yo+ is 8.7%
- Australian prevalence for 50 yo+ is 26.26%

Pathophysiology:
- A combination of factors from both the environment, the lifestyle, normal ageing changes and pathological changes.
- Genetic background, oxidative stress, lipid peroxidation, chronic inflammation, neovascularisation and fibrosis are key features.

8 Changes to Bruch's Membrane with age
1. Progressive thickening occurs
2. Lipid accumulates to restrict nutrient/waste transport
3. Basement membrane thickness means less elasticity or hydraulic permeability
4. Collagen cross-linking means decreased permeability, elasticity, flexibility
5. AGE accumulation decreases protein function
6. Proteoglycan size increases to decrease anti-inflammatory response
7. Elastic Layer calcification causes low elasticity, making the membrane brittle
8. Increased RPE breaking and defects causing choroidal neovascularisation (CNV)

Other effects of ageing:
- Choroidal ischaemia: progressive decrease in choroidal thickness and choriocapillaris density decreases choroidal blood flow. Could lead to hypoxia and up-regulation of angiogenesis.
- Oxidative stress: High metabolic activity by RPE increases ROS. Other factors include smoking

Dead Giveaways

Earliest Sign of AMD:

  • BLamD --> Basal laminar deposits are ECM material buildup between the RPE and the BM, and is protein and collagen rich

  • BLinD --> Basal linear deposits between RPE and Bruch's ICL, and is lipid rich

  • This sign cannot evaluated clinically, only by histology

  • B shows the BLamD and C(D) shows BLinD
    B shows the BLamD and C(D) shows BLinD

Drusen (Hallmark of AMD):

  • Deposits between the RPE basal lamina and the Bruch's ICL.

  • Contains lipid, proteins, cholesterol and carbohydrates

  • More about drusen is covered in myopic maculopathy

  • As the first clinical sign, its size is determined by the major inferior venule crossing the disc, which represents approximately 125 microns.

    Baseline
    Baseline
    • A small druplet is <63 microns

    • A medium drusen is between 63 and 125 microns

    • A large drusesn is >125 microns

  • Drusen can be reticular (located in the RPE) or cuticular drusen (looks like sawtooth)

    • Compared to standard drusen (C) underneath RPE, reticular pseudodrusen (D) appears to be in front
      Compared to standard drusen (C) underneath RPE, reticular pseudodrusen (D) appears to be in front
    • Sabretooth like appearance of the cuticular drusen
      Sabretooth like appearance of the cuticular drusen
  • Drusenoid Regression: Typically, drusen will grow before regression and undergoing atrophy

    • Typically, higher drusen loads are associated with higher progression risk

    • Regression occurs in 20-50% of AMD over 2 years

    • More likely in eyes with greater baseline drusen and volume

    • Overtime, these coalesce and becomes larger, with a strong association with late AMD (82%)

    • All cases of GA/MNV are preceded by drusen regression.


Pigmentary Abnormalities:

  • Describes the presence of any non-drusenoid hyper/hypo-pigmentation at the macula.

  • This indicates a risk of progression to late AMD

  • Hyperpigmentation is due RPE clumping, or increased pigmentation in RPE

  • Hypopigmentation is due to RPE atrophy and thinning, or loss of pigmentation in RPE


Inflammation (Hallmark of AMD):

  • Oxidative stress can induce proinflammatoy responses for chronic local inflammation

  • The presence of chronic local inflammation plays a role in both neo-vascular and non-neovascular AMD

  • Inflammation is mediated by the complement pathway

    • Mutations for example in complement H can increase inflammatory response

    • Excessive cell damage occurs and debris accumulates


Angiogenesis and CNV:

  • Formation of new BV

  • VEGF is a key regulator. With the calcification and thickening of Bruch's membrane, combined with a thin choriocapillaris and reduced blood flow, this can lead to retinal hypoxia which releases VEGF

  • This causes a breakdown of the outer BRB, with the abnormal blood vessels disrupting RPE/BM integrity, creating haemorrhages and fluid leakage.

  • Classic CNV: Well-defined, early leakage
    Classic CNV: Well-defined, early leakage
  • Occult CNV: Ill-defined, later and less leakage
    Occult CNV: Ill-defined, later and less leakage

Beckman Classification of AMD:

  • No apparent age changes = No drusen or pigmentary abnormalities

  • Normal age changes = Small druplets only, but no pigmentary abnormalities

  • Early AMD = medium drusen with no pigmentary abnormalities

    • Often asymptomatic with no vision loss

  • Intermediate AMD = Large drusen and/or ANY AMD pigmentary abnormalities

    • Reduced CS and dark adaptation, possible visual distortions

    • iRORA (incomplete RPE and outer retinal atrophy)

      Features similar to cRORA but smaller and only at intervals. Typically does not present in geographic atrophy, but is associated with a high risk of impending geographic atrophy
      Features similar to cRORA but smaller and only at intervals. Typically does not present in geographic atrophy, but is associated with a high risk of impending geographic atrophy
  • Late AMD = Neovascular AMD and/or ANY geographic atrophy + Requires at least 2 conversion risk factors

    • Geographic Atrophy: Atrophy of outer retina, PR, RPE and choriocapillaris >250 microns, typically beginning in perifoveal macula. Presents with insidious and gradual vision loss.

      • cRORA (complete RPE and outer retinal atrophy)

        Region of choroidal hypertransmission of 250 microns or more, with RPE attenuation or disruption. Overlying PR degeneration
        Region of choroidal hypertransmission of 250 microns or more, with RPE attenuation or disruption. Overlying PR degeneration
      • FAF can be very helpful in tracking progression

        Patterns can predict
        Patterns can predict
    • Neovascular: Whilst non-neovascular cases account for 80% of cases, vision loss is slowly progressive. Neovascular cases on the other hand accounts for 20% of cases, but 90% of severe vision loss. Vision loss can be sudden, causing scotoma or metamorphopsia

      From Nature, Bae K et al. 2019. Shows the OCT-A of neovascular AMD.  Comes with subretinal hyper-reflective material, fibrosis and scarring, PEDs, haemorrhages.
      From Nature, Bae K et al. 2019. Shows the OCT-A of neovascular AMD. Comes with subretinal hyper-reflective material, fibrosis and scarring, PEDs, haemorrhages.

diagnostic features

General Risk Factors:

  • Old age increases risk. 3x increase for 75 y/o compared to 65

  • Smoking

  • Family History

  • Cardiovascular risk factors (modifiable)

    • Hypertension

    • Hyperlipidaemia

    • Obesity

  • Nutrition and exercise (low dietary intake of vitamins A, C, and E, zinc, lutein, omega-3 fatty acid.


Genetic Risks:

  • Potential genetic influence suspected, and strong evidence.

  • Focuses on genes involved in modulation of the complement system and lipid metabolism

  • Genetic susceptibility combined with environmental factors contribute to disease onset and progression


Conversion Risk:

  • Single eye involvment + large drusen = 1 risk factor

  • Single eye involvement + pigmentary changes = 1 risk factor

  • Fellow eye involvement + large drusen/pigmentary changes = 1 risk factor

  • Both eye involvement with medium drusen = 1 risk factor

  • Late AMD = 2 risk factors


MNV:

  • Neovascularisation involving the macular

  • Type 1:

    • Located between Bruch's membrane and RPE, with ingrown vessels from the choriocapillaris extending into and under the RPE

    • Appears same as an occult lesion on fluorescein angiography

    • On OCT, presents as a PED wit heterogenous reflectivity, representing fibrovascular content

    • May have overlying haemorrhages.

  • Type 2:

    • Proliferation of new vessels that extend above the RPE into the subretinal space

    • Shows a hyper-reflective lesion (well defined) with intense leakage

    • Appears similar to the classic lesion on angiography

  • Type 3:

    • Downgrowth of vessels from the retinal circulation towards outer retina

    • Also known as retinal angiomatous proliferator or RAP lesion

    • OCT typically shows extension of hyper-reflectivity from the middle retina to the RPE as well as intraretinal fluid or cystic spaces


Prognostic Biomarkers for AMD:

  • Used to predict the risk or outcome of a disease in the population without therapy

  • Hyper-reflective Foci

    • 41% of AMD eyes

    • Dot-shaped intraretinal lesions at the apex of drusen

    • Typically corresponds with focal pigmentary abnormalities

  • Reticular Pseudodrusen

    • 9-58% of AMD eyes, and appear yellow-white

    • 2-6x higher risk of progression to advanced AMD

  • Nascent geographic atrophy (iRORA)

    • 7% of AMD eyes

    • Subsidence of OPl and INL and a hypo-reflective wedge, typically located within the central 1500 microns of macula

  • Sub-RPE hyper-reflective columns

    • Unknown prevalence, but appears as a pillar of increased transmission, preceding both GA and CNV

  • Drusen with subretinal fluid

    • Present in 11% of eyes. May represent subclinical CNV or mechanical strain

  • Drusen substructures

    • Present in 24% of eyes

    • Non-homogenous internal reflectivity variations within drusen

    • May be associated with GA

2025, made by Eric Qin. UNSW. SOVS

bottom of page